Australia markets open in 6 hours 16 minutes
  • ALL ORDS

    7,381.10
    +19.20 (+0.26%)
     
  • AUD/USD

    0.6928
    -0.0098 (-1.39%)
     
  • ASX 200

    7,127.70
    +22.30 (+0.31%)
     
  • OIL

    88.09
    +1.56 (+1.80%)
     
  • GOLD

    1,776.70
    -13.00 (-0.73%)
     
  • BTC-AUD

    33,811.75
    -861.84 (-2.49%)
     
  • CMC Crypto 200

    556.52
    -16.29 (-2.84%)
     

Why Bluebird Bio Stock Is Crashing Today

·2-min read
Why Bluebird Bio Stock Is Crashing Today
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Shares of Bluebird Bio (NASDAQ: BLUE) were crashing 23.3% lower as of 12:18 p.m. EDT on Monday. Bluebird said that the U.S. Food and Drug Administration (FDA) has placed a phase 3 study featuring eli-cel (also known as Lenti-D) on clinical hold. The company also stated that it plans to focus only on the U.S. market with its severe genetic disease products and pull out of the European market.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting